A Pilot Study of Vemurafenib and Panitumumab Combination Therapy in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer
Phase of Trial: Phase II
Latest Information Update: 25 Jan 2016
Price : $35 *
At a glance
- Drugs Panitumumab (Primary) ; Vemurafenib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 18 Mar 2015 Status changed from active, no longer recruiting to completed, according to to ClinicalTrials.gov record.
- 21 Aug 2014 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 27 Feb 2013 New source identified and integrated (Memorial Sloan-Kettering Cancer Center; 12-221).